Fresh Tracks Therapeutics (FRTX) Stock Price, News & Analysis

Company Overview

Fresh Tracks Therapeutics, Inc. does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.

Key Stats

• Today's Range: $0.94 to $0.94
• 50-Day Range: $0.91 to $0.94
• 52-Week Range: $0.03 to $1.03
• Volume: 2,402 shs
• Average Volume: 2,709 shs
• Market Capitalization: $5.58 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

FRTX Stock Analysis - Frequently Asked Questions

How have FRTX shares performed this year?

Fresh Tracks Therapeutics' stock was trading at $0.74 at the beginning of 2025. Since then, FRTX stock has increased by 26.4% and is now trading at $0.9350.
View the best growth stocks for 2025 here.

How do I buy shares of Fresh Tracks Therapeutics?

Shares of FRTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Fresh Tracks Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Fresh Tracks Therapeutics investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), e.l.f. Beauty (ELF), Disc Medicine (IRON), Jabil (JBL) and Adobe (ADBE).

Company Calendar

• Today: 4/26/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biological products, except diagnostic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:FRTX
• CIK: 819050
• Web: N/A
• Phone: (720) 505-4755
• Fax: 858-646-1150
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $10.06 million
• Price / Sales: 0.56
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.66 per share
• Price / Book: 0.56

Miscellaneous

• Outstanding Shares: 5,973,000
• Free Float: 5,959,000
• Market Cap: $5.58 million
• Optionable: Not Optionable
• Beta: 0.54